After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...
The Vertex drug is a milestone after a long history of unsuccessful efforts to develop painkillers without the addictive ...
They work at Vertex’s cystic fibrosis research center in San Diego and have collaborated for more than 20 years on four game-changing drugs that have won approval since 2012. “However ...
Vertex has gained the FDA's approval for its nonaddictive pain med Journavx, which becomes the first significant innovation ...
Vertex Pharmaceuticals Inc. (VRTX) has secured FDA approval for Suzetrigine, an oral, non-opioid, highly selective NaV1.8 pain signal ...
Approval of Journavx for acute pain marks the first new class of acute pain medication approved by the FDA in over 20 years.
"Options aside from opioids have been so desperately needed,” Dr. Jessica Oswald, Associate Physician in Emergency Medicine ...
The US Food and Drug Administration has approved the use of a novel painkiller as an effective treatment for short-term ...
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has ...
The U.S. Food and Drug Administration approved a new non-opioid pain medication developed by the Massachusetts-based company ...
The Food and Drug Administration on Thursday approved a new type of nonopioid painkiller from Vertex Pharmaceuticals, NBC ...
M.D., M.P.H., Associate Physician in Emergency Medicine and Pain Medicine in San Diego and Vertex Acute Pain Steering Committee Member. “I believe JOURNAVX could redefine the management of pain ...